Surface Oncology Company

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights.
Industry: P4 Medicine
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2014
Employees Number: 51-100
Funding Status: IPO
Total Funding: 63900000
Last Funding Type: Post-IPO Equity

Visit Website
info@labcentral.org
Register and Claim Ownership